E. De Vita, A. Bainbridge, J. Cheong, P. Kinchesh, A. Huertas-Ceballos, R. J. Ordidge, N. J. Robertson, E. B. Cady
{"title":"Localized 4.7 T Proton Magnetic Resonance Spectroscopy in Neonatal Encephalopathy: Implementation, Safety and Preliminary Interpretation of Results","authors":"E. De Vita, A. Bainbridge, J. Cheong, P. Kinchesh, A. Huertas-Ceballos, R. J. Ordidge, N. J. Robertson, E. B. Cady","doi":"10.1111/j.1617-0830.2005.00059.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Magnetic resonance (MR) techniques have revolutionized the assessment of brain development and injury in the newborn. MR studies at 3 T or above are becoming widespread; however, given the high cost and complexity of high-field MR systems, it is important to assess their benefits and limitations for clinical practice.</p>\n <p>MR spectroscopy (MRS) studies at high field carry potential benefits such as improved signal-to-noise ratio (SNR) and chemical shift dispersion compared with 1.5 T. However, safety is a very important consideration as radiofrequency (RF) tissue heating and acoustic noise also increase with field strength. Furthermore, increased chemical-shift dependence of the position of the volume of interest (VOI), shorter transverse and longer longitudinal relaxation times constitute additional challenges.</p>\n <p>We describe the first <i>in-vivo</i>, proton MRS studies of newborn human brain at 4.7 T. Nine infants with neonatal encephalopathy, all ventilated and with continuous physiological monitoring, were studied. We used L-FOCI localization, mostly with a VOI centred on the thalami.</p>\n <p>The absence of 4.7 T results from healthy infants made it impossible to interpret pathological metabolite peak-area ratios. However, concentration ratios and concentrations should be field-strength independent and interpretable using control values acquired at lower field. Of eight infants with concentration-ratio measurements, seven had low [<i>N</i>-acetylaspartate (NAA)]/[choline (Cho)] and three increased [lactate]/[NAA]. Of the two infants with ‘concentration’ measurements both had low [NAA] and one reduced [creatine].</p>\n <p>We used an adult coil and consequent RF power restrictions had repercussions for the minimum magnetization recovery time (TR). A smaller, neonatal coil should improve SNR and, with less RF power, relax TR constraints thereby enabling fuller exploitation of the potential of high-field MRS.</p>\n </div>","PeriodicalId":89151,"journal":{"name":"Imaging decisions (Berlin, Germany)","volume":"9 4","pages":"31-41"},"PeriodicalIF":0.0000,"publicationDate":"2005-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1617-0830.2005.00059.x","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Imaging decisions (Berlin, Germany)","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1617-0830.2005.00059.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Magnetic resonance (MR) techniques have revolutionized the assessment of brain development and injury in the newborn. MR studies at 3 T or above are becoming widespread; however, given the high cost and complexity of high-field MR systems, it is important to assess their benefits and limitations for clinical practice.
MR spectroscopy (MRS) studies at high field carry potential benefits such as improved signal-to-noise ratio (SNR) and chemical shift dispersion compared with 1.5 T. However, safety is a very important consideration as radiofrequency (RF) tissue heating and acoustic noise also increase with field strength. Furthermore, increased chemical-shift dependence of the position of the volume of interest (VOI), shorter transverse and longer longitudinal relaxation times constitute additional challenges.
We describe the first in-vivo, proton MRS studies of newborn human brain at 4.7 T. Nine infants with neonatal encephalopathy, all ventilated and with continuous physiological monitoring, were studied. We used L-FOCI localization, mostly with a VOI centred on the thalami.
The absence of 4.7 T results from healthy infants made it impossible to interpret pathological metabolite peak-area ratios. However, concentration ratios and concentrations should be field-strength independent and interpretable using control values acquired at lower field. Of eight infants with concentration-ratio measurements, seven had low [N-acetylaspartate (NAA)]/[choline (Cho)] and three increased [lactate]/[NAA]. Of the two infants with ‘concentration’ measurements both had low [NAA] and one reduced [creatine].
We used an adult coil and consequent RF power restrictions had repercussions for the minimum magnetization recovery time (TR). A smaller, neonatal coil should improve SNR and, with less RF power, relax TR constraints thereby enabling fuller exploitation of the potential of high-field MRS.